Polymorphism analysis of the CTLA-4 (rs231775) gene as a marker of inhibitor development in Iranian patients with hemophilia A

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Keshavarz Norouzpour M.; BOLHASSANI A.; SARI S.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download Full-Text

Persian Verion

View:

331

Download:

Cites:

Information Journal Paper

Title

Polymorphism analysis of the CTLA-4 (rs231775) gene as a marker of inhibitor development in Iranian patients with hemophilia A

Author(s)

Keshavarz Norouzpour M. | BOLHASSANI A. | SARI S. | Issue Writer Certificate

Keywords

Hemophilia AQ2

InhibitorQ1

CTLA-4Q2

Tetra ARMS PCRQ1

Abstract

Background: Development of factor VIII (FVIII) Inhibitor is the main problem of replacement therapy in patients with Hemophilia A. Recently, the correlation of polymorphisms of some genes involved in immune system has been determined with Inhibitor development. The reports showed that cytotoxic T lymphocyte antigen-4 (CTLA-4) plays an important role in regulating T cell activation and thus, CTLA-4 gene polymorphism is related to genetic susceptibility to various autoimmune diseases. This study aimed at investigating the correlation between polymorphism of CTLA-4 gene and Inhibitor development in Iranian Hemophilia A patients for the first time. Materials and Methods: In this case-control study, the genomic DNA was extracted from blood samples of 55 Inhibitor positive and 45 Inhibitor negative Hemophilia A patients. Then, the genotyping of the CTLA-4 gene was performed using the Tetra Primer ARMS PCR. Moreover, the validation of single nucleotide polymorphisms (SNPs) in the CTLA-4 gene was determined by DNA sequencing. On the other hand, the role of HCV infection was determined in Inhibitor-positive and Inhibitor-negative HA patients. Results: Results showed that no statistically significant difference was observed between the genotypic and allelic frequencies with the presence of Inhibitors (P>0. 05). Moreover, a significant correlation was observed between HCV infections and development of Inhibitors (P<0. 05). Conclusion: The CTLA-4 gene polymorphism does not play a role for inhibiting coagulation factor in Iranian patients with hemophilia type A.

Cites

No record.

References

No record.

Cite

APA: Copy

Keshavarz Norouzpour, M., BOLHASSANI, A., & SARI, S.. (2018). Polymorphism analysis of the CTLA-4 (rs231775) gene as a marker of inhibitor development in Iranian patients with hemophilia A. FEYZ, 22(1 ), 75-83. SID. https://sid.ir/paper/40760/en

Vancouver: Copy

Keshavarz Norouzpour M., BOLHASSANI A., SARI S.. Polymorphism analysis of the CTLA-4 (rs231775) gene as a marker of inhibitor development in Iranian patients with hemophilia A. FEYZ[Internet]. 2018;22(1 ):75-83. Available from: https://sid.ir/paper/40760/en

IEEE: Copy

M. Keshavarz Norouzpour, A. BOLHASSANI, and S. SARI, “Polymorphism analysis of the CTLA-4 (rs231775) gene as a marker of inhibitor development in Iranian patients with hemophilia A,” FEYZ, vol. 22, no. 1 , pp. 75–83, 2018, [Online]. Available: https://sid.ir/paper/40760/en

Related Journal Papers